首页 > 最新文献

NURSE PRACTITIONER最新文献

英文 中文
The Drug Update: Recent drug approvals, winter 2026 edition. 药物更新:最近的药物批准,2026年冬季版。
IF 0.9 Q4 NURSING Pub Date : 2026-02-01 Epub Date: 2026-01-22 DOI: 10.1097/01.NPR.0000000000000406
Adriane B Marino, Jenna D Theroux, Evan S Drake, Kendra Gemmill Hofler, Trent Long

Abstract: In the first half of 2025, the US FDA approved several new drugs that have relevance for those practicing in primary care. This article highlights the following new medications and vaccinations: suzetrigine (Journavx); gepotidacin (Blujepa); meningococcal groups A, B, C, W, and Y vaccine (Penmenvy); clesrovimab-cfor (Enflonsia); and acoltremon (Tryptyr). Additionally, this article highlights the recent approval of moderately to severely active Crohn's disease as a new indication for guselkumab (Tremfya).

摘要:2025年上半年,美国FDA批准了几种与初级保健相关的新药。本文重点介绍了以下新药物和疫苗:舒三嗪(Journavx);gepotidacin (Blujepa);脑膜炎球菌A、B、C、W和Y组疫苗(Penmenvy);clesrovimab-cfor (Enflonsia);和acoltreon (Tryptyr)。此外,本文强调了最近批准中度至重度活动性克罗恩病作为guselkumab (Tremfya)的新适应症。
{"title":"The Drug Update: Recent drug approvals, winter 2026 edition.","authors":"Adriane B Marino, Jenna D Theroux, Evan S Drake, Kendra Gemmill Hofler, Trent Long","doi":"10.1097/01.NPR.0000000000000406","DOIUrl":"https://doi.org/10.1097/01.NPR.0000000000000406","url":null,"abstract":"<p><strong>Abstract: </strong>In the first half of 2025, the US FDA approved several new drugs that have relevance for those practicing in primary care. This article highlights the following new medications and vaccinations: suzetrigine (Journavx); gepotidacin (Blujepa); meningococcal groups A, B, C, W, and Y vaccine (Penmenvy); clesrovimab-cfor (Enflonsia); and acoltremon (Tryptyr). Additionally, this article highlights the recent approval of moderately to severely active Crohn's disease as a new indication for guselkumab (Tremfya).</p>","PeriodicalId":51812,"journal":{"name":"NURSE PRACTITIONER","volume":"51 2","pages":"13-25"},"PeriodicalIF":0.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146020655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
When the Senses Go Silent: Integrating Chemosensory Assessment into Primary Care. 当感觉沉默:将化学感觉评估纳入初级保健。
IF 0.9 Q4 NURSING Pub Date : 2026-02-01 Epub Date: 2026-01-22 DOI: 10.1097/01.NPR.0000000000000401
Paule Valery Joseph
{"title":"When the Senses Go Silent: Integrating Chemosensory Assessment into Primary Care.","authors":"Paule Valery Joseph","doi":"10.1097/01.NPR.0000000000000401","DOIUrl":"https://doi.org/10.1097/01.NPR.0000000000000401","url":null,"abstract":"","PeriodicalId":51812,"journal":{"name":"NURSE PRACTITIONER","volume":"51 2","pages":"8-10"},"PeriodicalIF":0.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146020627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The past, present, and future of nurse practitioners (NPs) in Japan: The views of a graduate of the first class of NP students in Japan. 日本护士从业人员(NPs)的过去、现在和未来:日本第一届护士从业人员毕业生的观点。
IF 0.9 Q4 NURSING Pub Date : 2026-02-01 Epub Date: 2026-01-22 DOI: 10.1097/01.NPR.0000000000000403
Shigenori Shiotsuki, Miki Ono

Abstract: This report traces the trajectory of education and role development of nurse practitioners (NPs) in Japan from its beginnings to the present. An overview of the qualifications of advanced practice nursing roles, including NPs, is provided. The necessity of the NP role in the setting of the country's demographics and current health care system is discussed. Considerations for the future of the role are explored.

摘要:本报告追溯了日本护士从业人员(NPs)的教育和角色发展轨迹,从开始到现在。提供了高级实践护理角色(包括NPs)的资格概述。讨论了NP在国家人口统计和当前卫生保健系统设置中的作用的必要性。探讨了对该角色未来的考虑。
{"title":"The past, present, and future of nurse practitioners (NPs) in Japan: The views of a graduate of the first class of NP students in Japan.","authors":"Shigenori Shiotsuki, Miki Ono","doi":"10.1097/01.NPR.0000000000000403","DOIUrl":"https://doi.org/10.1097/01.NPR.0000000000000403","url":null,"abstract":"<p><strong>Abstract: </strong>This report traces the trajectory of education and role development of nurse practitioners (NPs) in Japan from its beginnings to the present. An overview of the qualifications of advanced practice nursing roles, including NPs, is provided. The necessity of the NP role in the setting of the country's demographics and current health care system is discussed. Considerations for the future of the role are explored.</p>","PeriodicalId":51812,"journal":{"name":"NURSE PRACTITIONER","volume":"51 2","pages":"41-45"},"PeriodicalIF":0.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146020649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
UpToDate®.
IF 0.9 Q4 NURSING Pub Date : 2026-02-01 Epub Date: 2026-01-22 DOI: 10.1097/01.NPR.0000000000000404
{"title":"UpToDate®.","authors":"","doi":"10.1097/01.NPR.0000000000000404","DOIUrl":"https://doi.org/10.1097/01.NPR.0000000000000404","url":null,"abstract":"","PeriodicalId":51812,"journal":{"name":"NURSE PRACTITIONER","volume":"51 2","pages":"12"},"PeriodicalIF":0.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146020657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Next-generation approaches in treatment of Helicobacter pylori infection in adults. 成人幽门螺杆菌感染的新一代治疗方法。
IF 0.9 Q4 NURSING Pub Date : 2026-02-01 Epub Date: 2026-01-22 DOI: 10.1097/01.NPR.0000000000000402
Bhisnauth Churaman, Tammy Sadighi, Amy Dudley, Loureen Downes

Abstract: Helicobacter pylori is present in half of the world's population and poses a significant health threat due to its widespread prevalence, increasing antibiotic resistance, and potential for causing cancer. The American College of Gastroenterology has developed a new clinical guideline providing recommendations for diagnosis, treatment, and tests of cure to improve eradication rates.

摘要:幽门螺杆菌(Helicobacter pylori)存在于世界上一半的人口中,由于其广泛流行,抗生素耐药性增加,并可能导致癌症,对健康构成重大威胁。美国胃肠病学学会制定了一项新的临床指南,为诊断、治疗和治愈试验提供建议,以提高根除率。
{"title":"Next-generation approaches in treatment of Helicobacter pylori infection in adults.","authors":"Bhisnauth Churaman, Tammy Sadighi, Amy Dudley, Loureen Downes","doi":"10.1097/01.NPR.0000000000000402","DOIUrl":"10.1097/01.NPR.0000000000000402","url":null,"abstract":"<p><strong>Abstract: </strong>Helicobacter pylori is present in half of the world's population and poses a significant health threat due to its widespread prevalence, increasing antibiotic resistance, and potential for causing cancer. The American College of Gastroenterology has developed a new clinical guideline providing recommendations for diagnosis, treatment, and tests of cure to improve eradication rates.</p>","PeriodicalId":51812,"journal":{"name":"NURSE PRACTITIONER","volume":"51 2","pages":"27-32"},"PeriodicalIF":0.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146020632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Next-generation approaches in treatment of Helicobacter pylori infection in adults. 成人幽门螺杆菌感染的新一代治疗方法。
IF 0.9 Q4 NURSING Pub Date : 2026-02-01 Epub Date: 2026-01-22 DOI: 10.1097/01.NPR.0000000000000410
{"title":"Next-generation approaches in treatment of Helicobacter pylori infection in adults.","authors":"","doi":"10.1097/01.NPR.0000000000000410","DOIUrl":"https://doi.org/10.1097/01.NPR.0000000000000410","url":null,"abstract":"","PeriodicalId":51812,"journal":{"name":"NURSE PRACTITIONER","volume":"51 2","pages":"32-33"},"PeriodicalIF":0.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146020670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Drug Update: Recent drug approvals, winter 2026 edition. 药物更新:最近的药物批准,2026年冬季版。
IF 0.9 Q4 NURSING Pub Date : 2026-02-01 Epub Date: 2026-01-22 DOI: 10.1097/01.NPR.0000000000000409
{"title":"The Drug Update: Recent drug approvals, winter 2026 edition.","authors":"","doi":"10.1097/01.NPR.0000000000000409","DOIUrl":"https://doi.org/10.1097/01.NPR.0000000000000409","url":null,"abstract":"","PeriodicalId":51812,"journal":{"name":"NURSE PRACTITIONER","volume":"51 2","pages":"25-26"},"PeriodicalIF":0.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146020683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letters to the Editor. 给编辑的信。
IF 0.9 Q4 NURSING Pub Date : 2026-02-01 Epub Date: 2026-01-22 DOI: 10.1097/01.NPR.0000000000000407
Julee Briscoe Waldrop, Staci S Reynolds
{"title":"Letters to the Editor.","authors":"Julee Briscoe Waldrop, Staci S Reynolds","doi":"10.1097/01.NPR.0000000000000407","DOIUrl":"https://doi.org/10.1097/01.NPR.0000000000000407","url":null,"abstract":"","PeriodicalId":51812,"journal":{"name":"NURSE PRACTITIONER","volume":"51 2","pages":"e1"},"PeriodicalIF":0.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146020600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bipolar major depression: A comprehensive review of pharmacotherapy. 双相抑郁症:药物治疗的综合回顾。
IF 0.9 Q4 NURSING Pub Date : 2026-02-01 Epub Date: 2026-01-22 DOI: 10.1097/01.NPR.0000000000000389
Gryan Garcia, Christy Cotner

Abstract: Bipolar major depression involves recurrent depressive episodes requiring balanced treatment. Effective options include quetiapine, lurasidone, and olanzapine-fluoxetine. Lamotrigine prevents episodes, lithium reduces suicide risk, and emerging treatments show promise. Antidepressant monotherapy is discouraged. A patient-centered approach optimizing efficacy, safety, and stability is essential.

摘要:双相重性抑郁症包括复发性抑郁发作,需要平衡治疗。有效的选择包括喹硫平、鲁拉西酮和奥氮平-氟西汀。拉莫三嗪可以预防发作,锂可以降低自杀风险,新兴的治疗方法显示出希望。不鼓励使用抗抑郁药单一疗法。以患者为中心优化疗效、安全性和稳定性至关重要。
{"title":"Bipolar major depression: A comprehensive review of pharmacotherapy.","authors":"Gryan Garcia, Christy Cotner","doi":"10.1097/01.NPR.0000000000000389","DOIUrl":"https://doi.org/10.1097/01.NPR.0000000000000389","url":null,"abstract":"<p><strong>Abstract: </strong>Bipolar major depression involves recurrent depressive episodes requiring balanced treatment. Effective options include quetiapine, lurasidone, and olanzapine-fluoxetine. Lamotrigine prevents episodes, lithium reduces suicide risk, and emerging treatments show promise. Antidepressant monotherapy is discouraged. A patient-centered approach optimizing efficacy, safety, and stability is essential.</p>","PeriodicalId":51812,"journal":{"name":"NURSE PRACTITIONER","volume":"51 2","pages":"34-40"},"PeriodicalIF":0.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146020583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recognizing and managing primary aldosteronism in hypertension. 认识和管理原发性高血压醛固酮增多症。
IF 0.9 Q4 NURSING Pub Date : 2026-01-01 Epub Date: 2025-12-23 DOI: 10.1097/01.NPR.0000000000000395
Bernadette Sherman

Abstract: All patients with hypertension should undergo screening for hyperaldosteronism. Treatment of primary aldosteronism may involve adrenalectomy and/or the use of mineralocorticoid receptor antagonists. Education is needed to enhance the diagnosis and treatment of these conditions.

摘要:所有高血压患者都应接受高醛固酮增多症筛查。原发性醛固酮增多症的治疗可能包括肾上腺切除术和/或使用矿皮质激素受体拮抗剂。需要教育来加强对这些疾病的诊断和治疗。
{"title":"Recognizing and managing primary aldosteronism in hypertension.","authors":"Bernadette Sherman","doi":"10.1097/01.NPR.0000000000000395","DOIUrl":"https://doi.org/10.1097/01.NPR.0000000000000395","url":null,"abstract":"<p><strong>Abstract: </strong>All patients with hypertension should undergo screening for hyperaldosteronism. Treatment of primary aldosteronism may involve adrenalectomy and/or the use of mineralocorticoid receptor antagonists. Education is needed to enhance the diagnosis and treatment of these conditions.</p>","PeriodicalId":51812,"journal":{"name":"NURSE PRACTITIONER","volume":"51 1","pages":"12-15"},"PeriodicalIF":0.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145812139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
NURSE PRACTITIONER
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1